Last reviewed · How we verify
NCT04350034: XboxBurn
Xbox Kinect Promote Physical Fitness and Lean Mass in Severely Burned Children
NA trial testing Xbox training in Burns in 40 participants. Completed in 20 September 2019.
20 September 2019
Quick facts
| Lead sponsor | Qassim University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 15 June 2016 |
| Primary completion | 20 September 2019 |
| Estimated completion | 20 September 2019 |
Drugs / interventions tested
- Xbox training
- Control group — full drug profile →
Conditions studied
- Burns — all drugs for Burns →
Sponsor
Qassim University
Who can join
Adults 10 to 15, any sex, with Burns. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The outcome measures included quadriceps muscle strength as measured using an isokinetic dynamometer, LBM is measured by DEXA and cardiopulmonary fitness was assessed by measuring VO2 peak during a standardized treadmill exercise test using the modified Bruce protocol. All outcome measures were evaluated immediately after discharge as baseline and after 12 weeks of intervention.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Impact of Kinect-based virtual reality training on physical fitness and quality of life in severely burned children: A monocentric randomized controlled trial.
Basha MA, Aboelnour NH, Aly SM, Kamel FAH. · · 2022 · cited 12× · PMID 33316436 · DOI 10.1016/j.rehab.2020.101471
Verify or expand the search:
- PubMed search for NCT04350034
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Burns
Currently open trials in the same condition.
- NCT07259668 — Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Thermal Burns · recruiting
- NCT07248930 — Lipopolysaccharide Adsorption (Efferon LPS NEO) in Children With Thermal Burns · recruiting
- NCT07313735 — The Effect of Cartoon Character-Printed Band Use During Burn Dressing on Fear, Stress, Pain, and Physiological Parameter · NA · recruiting
- NCT07142824 — Comparison Between Burn Dressing Using Tilapia-Fish Skin Versus Regular Dressing · NA · recruiting
- NCT07277166 — The Effect of Mobile Robot Assisted Gait Training on Gait Performance in Chronic Patients With Impaired Gait Function Af · NA · recruiting
Other Qassim University trials
Trials by the same sponsor.
- NCT07400432 — Acute Effects of Moderate-Intensity Continuous Exercise Versus HIIT on Cognitive Performance and Psychophysiological Res · NA · enrolling by invitation
- NCT07055659 — Enhancing Oral Hygiene in Children Through an Innovative Motivational Model · NA · active not recruiting
- NCT06873230 — Assessment of Empathy Levels in Dental Hygiene Students and Interns · not yet recruiting
- NCT06891495 — Evaluating an AI-Generated Health Podcast · recruiting
- NCT07443007 — Effects of Balance, Plyometric, and Combined Plyometric-Balance Training in Pediatric Burn Survivors · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04350034 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Qassim University
- Last refreshed: 16 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04350034.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing